Nucleolar localization of the ErbB3 receptor as a new target in glioblastoma
Tóm tắt
The nucleolus is a subnuclear, non-membrane bound domain that is the hub of ribosome biogenesis and a critical regulator of cell homeostasis. Rapid growth and division of cells in tumors are correlated with intensive nucleolar metabolism as a response to oncogenic factors overexpression. Several members of the Epidermal Growth Factor Receptor (EGFR) family, have been identified in the nucleus and nucleolus of many cancer cells, but their function in these compartments remains unexplored. We focused our research on the nucleolar function that a specific member of EGFR family, the ErbB3 receptor, plays in glioblastoma, a tumor without effective therapies. Here, Neuregulin 1 mediated proliferative stimuli, promotes ErbB3 relocalization from the nucleolus to the cytoplasm and increases pre-rRNA synthesis. Instead ErbB3 silencing or nucleolar stress reduce cell proliferation and affect cell cycle progression. These data point to the existence of an ErbB3-mediated non canonical pathway that glioblastoma cells use to control ribosomes synthesis and cell proliferation. These results highlight the potential role for the nucleolar ErbB3 receptor, as a new target in glioblastoma.
Tài liệu tham khảo
Bersaglieri C, Santoro R. Genome organization around the nucleolus. Cells. 2019;8:579.
Boisvert FM, Van Koningsbruggen S, Navascues J, Lamond AL. The multifunctional nucleolus. Nat Rev Mol. 2007;8:574–85.
Chen L, Chen J. MDM2-ARF complex regulates p53 sumoylation. Oncogene. 2003;22:5348–57.
Ponti D, Bellenchi GC, Puca R, Bastianelli D, Maroder M, Ragona G, et al. The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesis. PLoS One. 2014. https://doi.org/10.1371/journal.pone.0096037.
Ponti D, Bastianelli D, Rosa P, Pacini L, Ibrahim M, Rendina EA, et al. The expression of B23 and EGR1 proteins is functionally linked in tumor cells under stress conditions. BMC Cell Biol. 2015;16:27.
Stefanovsky V, Langlois F, Gagnon-Kugler T, Rothblum LI, Moss T. Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and R-chromatin remodeling. Mol Cell. 2006;21:629–39.
Scherl A, Couté Y, Déon C, Callé A, Kindbeiter K, Sanchez JC, et al. Functional proteomic analysis of human nucleolus. Mol Biol Cell. 2002;3:4100–41092.
Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3:179–92.
Weeks SE, Metge BJ. The nucleolus: a central response hub for the stressors that drive cancer progression. Cell Mol Life Sci. 2019;76:4511–24.
Cerqueira AV, Lemos B. Ribosomal DNA and nucleolus as keystones of nucleolar architecture organization and function. Trends Genet. 2019;10:P710–23.
Andersen JS, Lyon CE, Fox AKL, Leung AKL, Lam YW, Steen H, et al. Directed proteomic analysis of human nucleolus. Curr Biol. 2002;12:1–11.
Ueshima S, Nagata K, Okuwaki M. Internal associations of the acidic region of upstream binding factor control its nucleolar localization. Mol Cell Biol. 2017;37:e00218–17.
Andrique L, Fauvin D, Maassarani M, Colasson H, Vannier B, Séité P. ErbB3 80kDa, a nuclear variant of the ErbB3 receptor, binds to the Cyclin D1 promoter to activate cell proliferation but is negatively controlled by p14ARF. Cell Signal. 2012;24:1074–85.
Kruspig B, Monteverde T, Neidler S, Hock A, Kerr E, Nixon C, et al. The Erbb network facilitates KRAS-driven lung tumorigeneis. Sci Transl Med. 2018. https://doi.org/10.1126/scitranslmed.aao2565.
Wang Z. ErbB receptors and cancer. In: Wang Z, editor. ErbB receptor signaling. Methods in molecular biology, vol 1652. New York: Humana Press; 2017. https://doi.org/10.1007/978-1-4939-7219-7_1.
Wang YN, Yamaguchi H, Hsu JM, Hung MC. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene. 2010;29:3997–4006.
Giri DK, Ali-Seyed M, Li LY, Lee DF, Ling P, Bartholomeusz G, et al. Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. Mol Cell Biol. 2005;25:11005–18.
Ni CY, Murphy MP, Golde TE, Carpenter G. C-Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science. 2001;294:2179–81.
Sihanandam G, Anderson LM. The ERBB3 receptor in cancer and cancer gene therapy. Cancer Gene Ther. 2008;15:413–48.
Thompson M, Lauderdale S, Webster MJ, Chong VZ, McClintock B, Saunders R, et al. Widespread expression VZ of ErbB2, ErbB3 and ErbB4 in non-human primate. Brain Brain Res. 2007;1139:95–109.
Adilakshmi T, Ness-Myers J, Madris-Aliste C, Fiser A, Tapinos N. A nuclear variant of ErbB3 receptor tyrosine kinase regulates Ezrin distribution and Schwann cell myelination. J Neurosci. 2011;31:5106–19.
Kancha RK, Von Buboff N, Duyster J. Asymmetric kinase dimer formation is crucial for the activation of oncogenic EGFRvIII but not for ERBB3 phosphorylation. Cell Commun Signal. 2013;11:39.
Chen B, Mao R, Wang H, She JX. Cell line and drug-dependent effect of ERBB3 on cancer cell proliferation, chemosensitivity, and multidrug actions. Int J High Throughput Screen. 2010;1:49–55.
Frogne T, Benjaminsen RV, Sonne-Hansen K, Sorensen BS, Nexo BS, Laenkholm AV, et al. Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant 2009. Breast Cancer Res Treat. 2009;11:263–75.
Aguilar Z, Akita RW, Finn RS, Ramos BL, Pegram MD, Kabbinavar FF, et al. Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells. Oncogene. 1999;18:6050–62.
Wolfson E, Solomon S, Schmukler E, Goldshmit Y, Pinkas-Kramarski R. Nucleolin and ErbB2 inhibition reduces Tumorigenicity of ErbB2-positive breast cancer. Cell Death Dis. 2018;9:47.
Mi Y, Thomas SD, Xu X, Casson LK, Miller DM, Bates PJ. Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin. J Biol Chem. 2003;278:8572–9.
Ma H, Pederson T. The nucleolus stress response is coupled to an ATR-Chk1-mediated G2 arrest. Mol Biol Cell. 2013;24:1334–42.
Auf G, Jabouille A, Delugin M, Guérit S, Pineau R, North S, et al. High Epiregulin expression in human U87 Glioma cells relies on IRE1α and promotes Autocrine growth through EGF receptor. BMC Cancer. 2013;13:597.
Ritch PS, Carroll SL, Sontheimer H. Neuregulin-1 enhances survival of human Astrocytic Glioma cells. Glia. 2005;51:217–28.
Wilson TR, Lee DY, Berry L, Shames DS, Settleman J. Neuregulin-1-mediated Autocrine signaling underlies sensitivity to HER2 kinase inhibitors in a subset of human cancers cancer. Cell. 2011;20:158–72.
Clark PA, Lida M, Treisman DM, Kalluri H, Ezhilan S, Zorniak M, et al. Activation of multiple ERBB family receptors mediates Glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition. Neoplasia. 2012;14:420–8.
Naidu R, Yadav M, Nair S, Kutty MK. Expression of C-ERBB3 protein in primary breast carcinomas. Br J Cancer. 1998;78:1385–90.
Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, et al. Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A. 1991;88:7792–6.
Hayashi M, Inokuchi M, Takagi Y, Yamada H, Kojima K, Kumagai J, et al. High expression of HER3 is associated with a decreased survival in gastric cancer. Clin Cancer Res. 2008;14:7843–9.
Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J, et al. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008;27:5195–203.
Rampogu S, Son M, Baek A, Park C, Rana RM, Zeb A, et al. Targeting natural compounds against HER2 kinase domain as potential anticancer drugs. Applying Pharmacophore based molecular Modelling approaches. Comput Biol Chem. 2018;74:327–38.
Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455:061–1068.
Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Cancer genome atlas research network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17:98–110.
Song K, Yuan Y, Lin Y, Wang YX, Zhou J, Gai QJ, et al. ERBB3, IGF1R, and TGFBR2 expression correlate with PDGFR expression in Glioblastoma and participate in PDGFR inhibitor resistance of Glioblastoma. Cells Am J Cancer Res. 2018;8:792–809.
Hsu S-C, Hung M-C. Characterization of a novel tripartite nuclear localization sequence in the EGFR family. J Biol Chem. 2007;82:10432–40.
Reif R, Adawy A, Vartak N, Schröder J, Günther G, Ghallab A, et al. Activated ErbB3 translocates to the nucleus via clathrin-independent endocytosis which is associated with proliferating cells. J Biol Chem. 2016;291:3837–47.
Balça-Silva J, Do Carmo A, Tão H, Rebelo O, Barbosa M, Moura-Neto V, et al. Nucleolin is expressed in patient-derived samples and glioblastoma cells, enabling improved intracellular drug delivery and cytotoxicity. Exp Cell Res. 2018;370:68–77.
Taylor JT, Ellison S, Pandele A, Wood S, Nathan E, Forte G, et al. Actinomycin D Downregulates Sox2 and improves survival in preclinical models of recurrent Glioblastoma. Neuro-Oncology. 2020. https://doi.org/10.1093/neuonc/noaa051.
Avitabile D, Genovese L, Ponti D, Ranieri D, Raffa S, Calogero A, et al. Nucleolar localization and circadian regulation of Per2S, a novel splicing variant of the period 2 gene. Cell Mol Life Sci. 2014;71:2547–59.
Rosa P, Zerbinati C, Crestini A, Canudas AM, Ragona G, Confaloni A, et al. Heme Oxygenase-1 and brain Oxysterols metabolism are linked to Egr-1 expression in aged mice cortex, but not in hippocampus. Front Aging Neurosci. 2018;10:363.